• DXY breakout above key resistance suggests dollar strength is returning after months of consolidation.
• Crude Oil ↓ – Typically moves inversely to DXY as a stronger dollar makes oil more expensive globally.
• Bitcoin ↓ – Dollar strength often drains liquidity from speculative assets, creating pressure on crypto markets.
• Nasdaq 100 & S&P 500 ↓ – Higher DXY is generally bearish for growth stocks and risk assets due to tighter financial conditions.
• Russell 2000 ↓ – Small-cap stocks tend to underperform when the dollar strengthens and financial conditions tighten.
• Gold ↔ / ↓ – Mixed relationship, but sustained DXY rallies often limit upside in gold prices.
• VIX ↑ – The only major asset in the chart showing a positive correlation with DXY; rising dollar strength is often accompanied by higher market volatility.

• Market Implication: If the weekly DXY breakout holds, it could signal increasing pressure on equities, crypto, and commodities while supporting a rise in volatility.

• SPY is approaching a fresh all-time high, with price reclaiming the prior consolidation range and now trading near the upper half of the highlighted resistance zone around $763-$765.
• The recent pullback held key support near $732, and buyers stepped in aggressively, producing a strong V-shaped recovery that suggests bullish momentum remains intact.
• Higher highs and higher lows continue to develop on the daily timeframe, keeping the broader uptrend firmly in place and increasing the probability of a breakout above previous highs.
• Price has already absorbed a sharp profit-taking move from the recent peak, yet managed to recover quickly, indicating underlying demand and limited selling pressure at current levels.
• A sustained move above the $755 area could open the door to a fresh all-time high test near $763-$765, with momentum favoring continuation as long as SPY remains above the $732-$745 support region.

NYSE: PGR | P&C Insurance (Auto / Home / Commercial) | Mkt Cap ~$119B | Price ~$203

Progressive is the gold standard of personal-auto underwriting — best-in-class data/telematics (Snapshot), the lowest expense ratio in the industry, and the fastest policy growth among the majors. It almost NEVER gets cheap. Right now it trades at ~10x earnings, down ~30% from its high, near 52-week lows. That's the setup: a wonderful business at an unusually un-wonderful multiple… because the market thinks 2024-25 was peak profitability. Here's the breakdown.

⚠️ UPFRONT: This is NOT a reversal yet — PGR is below its 200-day MA and near 52-week lows. It's a quality-compounder-on-discount thesis, with a real peak-margin debate attached. Trade it accordingly.

━━━━━━━━━━━━━━
*  TECHNICALS (Trend)

• The de-rate: From a ~$290 high (52-wk), PGR has pulled back ~30% to ~$203 — a rare drawdown for this name.
• 52-week range: ~$191.75 low → $289.96 high. Price sits in the BOTTOM third, ~6% off the low.
• Trend is DOWN: Below the 200-day MA (~$219). Below = corrective. No confirmed bottom yet.
• What a turn needs: hold the ~$192 52-week low, then reclaim the 200-day (~$219) to flip the trend back constructive.
• Downside: a clean break under $192 opens the low-$180s / fills the gap toward longer-term support.

━━━━━━━━━━━━━━
🏢 THE BUSINESS

• #1 in growth: Policies in force +8% YoY to ~39.8M; Direct auto +11%, Agency auto +8%. Taking share in a hard market.
• The moat: superior segmentation/pricing (decades of telematics data), the lowest expense ratio in the industry, and a dual agency + direct distribution model.
• Disciplined to the core: Progressive targets a ~96 combined ratio and a 4% underwriting margin — and consistently beats it. Underwriting profit, not just float, is the engine.
• Diversifying: growing Property (home) and Commercial auto alongside the personal-auto cash cow.

━━━━━━━━━━━━━━
💰 LATEST NUMBERS

Q1 2026:
• Net income: $2,818M, +10% YoY | Combined ratio: 86.4 (still highly profitable)

April 2026:
• Net premiums written: $7.28B, +6% | Net premiums earned: $7.11B, +7%
• Net income: $1,087M, +10% | EPS: $1.86
• Combined ratio: 90.2 — BUT deteriorated 530bps from 84.9 a year ago. This margin normalization is the whole bear case.
• Book value/share: $56.29, +8.9% YoY — steady compounding underneath.
• PIF: +8% to 39.77M. Growth engine still running hot.

━━━━━━━━━━━━━━
💵 VALUATION — The Crux

• ~10x trailing earnings (EPS ~$19.29). PGR's 10-YEAR AVERAGE P/E is ~25 — it's trading ~56% below its own historical norm. That almost never happens.
• P/B ~3.6x (book $56.29) — a premium to book, as quality insurers should be, but compressed from peak.
• The bull read: you're buying a 40%-ROE-caliber franchise at a single-digit-ish multiple.
• The bear read: the 'cheap' P/E sits on PEAK earnings. If 2024-25 underwriting margins were the top and the combined ratio keeps drifting toward ~96, forward EPS flattens — and ~10x peak EPS isn't actually cheap. THIS is the debate.

━━━━━━━━━━━━━━
💸 ABOUT THAT 6.8% 'YIELD' 

• The ~6.8% trailing yield is MISLEADING. Progressive pays a tiny regular dividend (~$0.40/yr, ~0.2%) PLUS a large VARIABLE annual dividend tied to that year's profits.
• The fat trailing yield reflects record 2024-25 profits. As margins normalize, the variable payout shrinks. Do NOT underwrite this as a stable 6-7% income stock.

━━━━━━━━━━━━━━
 COMPETITIVE LANDSCAPE

• GEICO (Berkshire) — the scale rival in direct auto, now re-accelerating its own tech/growth.
• Allstate (ALL), State Farm (private), Travelers (TRV) — the agency/multiline giants.
• PGR's edge: it out-segments and out-grows them, with a structurally lower expense ratio. The risk: GEICO catching up + an industry-wide softening of the auto-rate cycle.

━━━━━━━━━━━━━━
*  BULL CASE
• Elite franchise at ~10x — ~56% below its 10-yr average multiple. Rarely this cheap.
• Still GROWING fast: PIF +8%, Direct auto +11% — share gains compound for years.
• Best underwriting + lowest expense ratio in the industry = structural advantage.
• Book value compounding ~9%/yr; rising investment yields add a tailwind.
• If the market is wrong about 'peak margins,' the re-rating back toward 15–20x is huge.

•  BEAR CASE
  • PEAK-EARNINGS TRAP: combined ratio deteriorating (84.9 → 90.2 YoY). Cheap P/E on possibly-peak EPS isn't truly cheap.
  • Downtrend: below 200-day, near 52-week lows — no bottom confirmed.
  • The 6.8% 'yield' is variable and likely to shrink — income investors may be disappointed.
  • Auto-rate cycle softening + GEICO resurgence could pressure growth and pricing power.
  • Earnings increasingly flattered by realized investment gains vs pure underwriting.

━━━━━━━━━━━━━━
*  GAME PLAN

• This is a quality name on discount — but respect the downtrend. Don't catch it blind.
• Confirmation trigger: hold ~$192 (52-wk low) and reclaim the 200-day ~$219 → trend flips constructive.
• Targets (if it bases): $219 (200-day) → $238–252 (analyst avg) → $290 (prior high) on a full margin/multiple recovery.
• Invalidation: decisive break under ~$192 = low-$180s risk; reassess the peak-margin thesis.
• The asymmetric bet: best-in-class compounder, fastest grower, at the cheapest multiple in a decade — IF underwriting margins are normalizing (not collapsing) and the rate cycle holds. The 'peak earnings' question is the entire trade.

Key Levels

• Resistance: 750–754 (recent high / potential breakout zone)
• Support: 722 (gap-fill area), then 700 (major range support)
• Bias: Very Short term Bullish above 700, with near-term consolidation or gap-fill before a potential push to new highs.

• Bullish Momentum Intact: QQQ remains in a strong uptrend, with buyers quickly reclaiming recent weakness and keeping the broader bullish structure intact.
• Gap Fill Likely First: A short-term pullback toward the gap created by today's gap-up open would be healthy and could set up the next move higher over the next 1–2 sessions.
• New ATHs Possible: Momentum supports a breakout to fresh all-time highs, but a gradual move above the previous peak is more likely than a parabolic rally.
• Key Support Zone: The 700–722 area remains a major support region. Holding above this range keeps the bullish outlook unchanged.
• VIX Warning Signal: The VIX is sitting near historically low levels and approaching a major support zone, increasing the probability of a volatility spike and higher market swings ahead.

• QQQ remains range-bound in the short term, with price currently rebounding from the lower support zone near 700–703.
• The key resistance area sits at 721–724, which aligns with prior supply and recent rejection levels.
• A move into this resistance zone could attract selling pressure, increasing the probability of a short-term pullback.
• If rejection occurs near 721–724, price may rotate back toward the range support area, making 700–703 the key downside level to monitor.
• Better to WAIT for the range breakout with closing, then we can expect a big move either downside or upside based on the closing, but be alert, there might be a TRAP also with fake breakdown or Breakout.

NYSE: EVTC | FinTech / Payment Processing (Puerto Rico + Latin America) | Mkt Cap ~$1.4B | Price ~$22

Evertec runs the payment rails of Puerto Rico, the Caribbean & Latin America — the ATH network, merchant acquiring, card processing, and core-bank software. The business is GROWING (revenue +10% in 2025, guidance just RAISED for 2026), it trades at a single-digit earnings multiple… and the stock just made a new 52-week low. That tension is the whole thesis. Here's the breakdown.

UPFRONT: Unlike a classic reversal setup, EVTC is NOT basing — it's in a confirmed downtrend at the lows. This is a value/contrarian idea, not a momentum buy. Trade it accordingly.

━━━━━━━━━━━━━━
 TECHNICALS (Monthly / Trend)

• The long bleed: From a ~$49.71 all-time-high close (Dec 2021), EVTC has been cut ~55% and is now grinding ~$22 — fresh 52-week lows.
• Range: 52-week band roughly $22 → $38.56. Price is pinned at the very bottom of it.
• Trend is DOWN: Death cross in place (50-day below 200-day), price below all major moving averages, momentum weak. No reversal signal yet.
• What a turn would need: First reclaim ~$25–26 and stop making lower lows, then a push back through the $28–29 shelf (the early-2026 pivot). Until then, every bounce is suspect.
• Downside risk: A clean break under ~$22 opens air toward the high-teens — there's limited visible support below the lows.

━━━━━━━━━━━━━━
🏢 THE BUSINESS

• Dominant in its backyard: Owns the ATH debit network in Puerto Rico and processes ~10B+ transactions/year across 26 countries.
• Four segments: Payment Services (PR & Caribbean), Latin America Payments & Solutions, Merchant Acquiring, Business Solutions.
• Diversifying away from PR: ~46% of revenue now comes from OUTSIDE Puerto Rico — a deliberate, M&A-fueled shift into Latin America.
• Sticky & recurring: Core-bank processing and payment rails are mission-critical, high-switching-cost infrastructure.

━━━━━━━━━━━━━━
💰 LATEST NUMBERS

FY2025:
• Revenue: $931.8M, +10.2% YoY
• GAAP Net Income: $141.6M, +25.7% ($2.20/sh)
• Adjusted EBITDA: $373.4M, +9.7% | Adjusted EPS: $3.62, +10.4%

Q1 2026:
• Revenue: $247.9M, +8% (record-ish growth, ~5% constant currency)
• Adjusted EBITDA: $97.0M, +9% | Adjusted EPS: $0.90, +3%
• BUT GAAP Net Income: -27% to $23.8M ($0.38/sh) — hit by higher amortization from acquired intangibles, integration costs, and FX losses. This GAAP/adjusted gap is exactly why the market got nervous.

Guidance RAISED for FY2026:
• Revenue: $1,073M–$1,085M (~15–16% growth) — up from prior ~10–11%, lifted by the Dimensa deal
• Adjusted EPS: $3.86–$3.98 (~7–10% growth)

━━━━━━━━━━━━━━
💵 VALUATION — The Core of the Bull Case

• ~6x forward adjusted EPS (~$22 / ~$3.92 mid-guide). For a recurring-revenue payments processor, that's dirt cheap.
• ~10x trailing GAAP earnings; PEG around 0.45 at the lows — paying well below the growth rate.
• Dividend: $0.20/yr (~0.9% yield), 14 consecutive years of payments + active buybacks.
• The multiple says the market is pricing in either a growth stall, a PR collapse, or balance-sheet stress — NOT a +15% revenue grower. If none of those break, there's a re-rating case.

━━━━━━━━━━━━━━
🧩 THE M&A ROLL-UP STORY

• Tecnobank (Oct 2025), Dimensa (~$181M, Apr 2026), BBChain (May 2026) — aggressive LatAm expansion.
• Dimensa: Brazilian B2B fintech, ~95% recurring revenue, ~65% share in insurance software — pushes EVTC into NEW verticals (insurance, risk) and "amongst the largest financial SaaS providers" in the region per the CEO.
• The catch: M&A is what's pressuring GAAP earnings (amortization) and adding leverage. Synergies aren't expected until 2027. The story is real but back-end loaded.

━━━━━━━━━━━━━━
 COMPETITIVE LANDSCAPE

• Global giants: FIS, Fiserv, Global Payments, Visa.
• LatAm fintech: dLocal (DLO), StoneCo (STNE), PagSeguro, Payoneer.
• EVTC's edge: entrenched local rails (ATH), regulatory know-how, and bank relationships in markets the giants under-serve. Its moat is regional, not global.

━━━━━━━━━━━━━━
ANALYST VIEW

• Consensus: HOLD (a few Buys).
• Avg 12-mo target ~$35.80 (range $29–$43) — implies large upside from ~$22, BUT targets look stale vs the recent drop. Expect downward revisions if weakness persists.

━━━━━━━━━━━━━━
✅ BULL CASE
• ~6x forward earnings for a double-digit revenue grower — deep value if the model holds.
• LatAm diversification (now ~46% of revenue) reduces PR dependence over time.
• Sticky, recurring, mission-critical infrastructure with real switching costs.
• Management raising guidance + buying back stock at the lows.
• Insurance/risk verticals (Dimensa) = new growth lanes.

 BEAR CASE
• Confirmed downtrend — fresh 52-week lows, death cross, no reversal signal. Catching it now is catching a falling knife.
• Puerto Rico concentration: macro fragility + long-term population decline.
• Customer concentration: ~29% of 2025 revenue tied to ONE relationship (Banco Popular).
• Leverage: ~$1.1B debt vs ~$672M equity — M&A-funded, rate/FX sensitive.
• GAAP earnings eroding on amortization & FX; synergies not until 2027.
• FX volatility (Brazilian real) can swing reported results.

━━━━━━━━━━━━━━
 GAME PLAN

• This is a WATCH, not a chase. Don't buy strength that isn't there yet.
• Reversal trigger: reclaim $25–26 + stop printing lower lows → then $28–29 confirms a base.
• Targets (IF it bases): $28–29 → $33–35 → analyst avg ~$36.
• Support / invalidation: losing ~$22 on a monthly basis = high-teens risk; size small and define your stop.
• The asymmetric bet: a cheap, growing, cash-generative payments rail that the market has left for dead — high reward IF the downtrend breaks and PR/leverage fears prove overblown. The "if" is doing a lot of work here.

• Primary trend remains bullish: SPY is still making higher highs and higher lows on the daily timeframe after the strong rally from the April lows. The recent selloff looks like a pullback within an uptrend rather than a confirmed trend reversal.
• Key resistance: 745–750 zone: Price is currently sitting just below the 745 resistance area (marked on your chart). A daily close above 745 could trigger another move toward the recent highs near 758–760.

Support levels to watch:

• First support: 732.4
• Major support: 722.9
• Volume suggests distribution/caution: The sharp red candles near the highs came with elevated volume, indicating profit-taking and increased selling pressure. Bulls need stronger buying volume to reclaim momentum.
• Most likely short-term scenario: SPY may continue consolidating between 723 and 745, producing choppy price action. A break above 745 would favor a bullish continuation, while a break below 723 could open the door for a deeper correction toward the 710–715 area.

Bias: Neutral-to-bullish above 723, bearish only on a confirmed breakdown below 723.

Current Price: $716.07 | Key Range: ~$700 – $722
* Key Levels to Watch

• Resistance: $721.94 – $723 (50% retracement / recent highs)
• Support / Breakdown trigger: $700.31
• Measured downside target (post-breakdown): ~$680–685

Base Case — Inside Bar / Range-Bound Week

• QQQ is currently consolidating within a well-defined range, with price action suggesting an inside bar formation is likely to develop this week
• The market is expected to respect both the upper and lower bounds of the current consolidation zone, with no meaningful directional breakout anticipated in the near term
• Price is hovering near the 50% retracement level (~$721–722), which is acting as a ceiling, capping upside momentum

⚡ Intraweek Volatility — Watch For Whipsaws

• Despite range-bound expectations, elevated intraweek volatility is anticipated — expect sharp moves in both directions that ultimately resolve back within the consolidation band
• This volatility is likely to be noise rather than signal, and traders should avoid chasing intraweek moves without confirmation

🔻 End-of-Week Risk — Breakdown Watch

• The critical scenario to monitor develops into the close of the week — there is a high probability that the consolidation phase resolves to the downside rather than the upside
• A confirmed breakdown below the lower boundary of the consolidation zone (~$700 support) would signal a bearish continuation move
• Such a breakdown could trigger an additional 4–5% decline from current levels, bringing QQQ toward the $680–685 zone
• Volume behaviour and the nature of the weekly close will be the key confirmation trigger — a weak, low-conviction close near the lows significantly raises breakdown probability

NASDAQ: ALGN | MedTech / Digital Dentistry (Invisalign + iTero) | Mkt Cap ~$12B | EV ~$11B | Price ~$172

Align owns the clear-aligner category it invented — Invisalign + iTero scanners + exocad software. After a brutal ~80%+ de-rate from its 2021 bubble peak, the business is quietly back to growth, throwing off cash, and the chart just broke a 2.5-year downtrend. Here's the full breakdown.

 TECHNICALS (Monthly Chart)

• The full round-trip: ALGN ran to a ~$700+ all-time high in late 2021, then collapsed ~80%+ to a ~$120 low in 2025 — one of the ugliest large-cap MedTech de-ratings of the cycle. The bubble premium is fully gone.

• Base is in: Multi-quarter base in the $120–150 zone, now recovering hard to ~$172 (+40%+ off the lows). First sustained higher-low structure after years of one-way selling.

• DOWNTREND LINE BREAK: The key event — price has pushed up into/through the multi-year descending trendline off the 2023 highs. Breaking a 2.5-year falling trendline is a structural shift, not just a bounce.

• Line in the sand — MA cluster $182–183: Price is testing the moving-average cluster overhead. A monthly close back above ~$183 flips the longer-term structure bullish. Until then it's resistance.

• Next resistance ~$231: The heavier declining MA + 2024 supply sits up here — the next major hurdle.

• Volume: Heavy capitulation-style volume into the 2025 lows, with buy volume now building on the recovery legs. Accumulation signature, not dead-cat.

• Current candle: Backtesting the breakout zone intra-month (low ~$160). Holding the $160s keeps the reversal intact.

━━━━━━━━━━━━━━
🏢 THE BUSINESS

• Category creator & volume leader in clear aligners — Invisalign is the reference brand globally.
• Two engines: Clear Aligner (~80% of revenue) + Systems & Services (iTero scanners, software).
• Razor/razorblade flywheel: iTero scanners lock doctors into the Invisalign ordering ecosystem.
• SmileDirectClub — the DTC disruptor that once scared this stock — went bankrupt in 2023. The premium doctor-channel model won.

━━━━━━━━━━━━━━
💰 LATEST NUMBERS (Q1 FY2026, reported in April)

• Revenue: $1.04B, +6.2% YoY — back to growth.
• Clear Aligner rev: $856M, +7.4% YoY on RECORD case shipments of ~686K (+6.7%).
• Gross margin: 70.8% (expanding ~1.4pts) — premium economics intact.
• Non-GAAP operating margin: ~21.5%.
• Non-GAAP EPS: $2.58 — beat estimates by ~12%.
• Balance sheet: ~$1.06B cash, effectively net cash. Strong FCF.
• Capital return: New $200M buyback authorized (May 2026) — management buying its own stock down here.

💵 VALUATION — Where the Thesis Lives

• ~15x normalized P/E and ~3x sales — vs the 40x+ multiples it carried at the 2021 top.
• This is the cheapest ALGN has been on earnings in its public life, despite ~70% gross margins and a net-cash balance sheet.
• You're no longer paying a hyper-growth premium — you're paying a mid-teens multiple for the category leader. The re-rating risk is now to the UPSIDE if growth re-accelerates.

⚔️ PEERS & COMPETITIVE LANDSCAPE

• The market went from single-player to multi-polar: Envista (Spark), Dentsply Sirona (SureSmile + Byte relaunch), Straumann (ClearCorrect), 3M Clarity, and China's Angel Aligner are all taking share.
• BUT the top players still control ~86% of a structurally GROWING market (clear aligners forecast double-digit CAGR as they keep eating wire-and-bracket share).
• ALGN remains the volume leader at the premium clinical end — the question is share trajectory, not survival.
• V/s diversified dental peers (XRAY, NVST), ALGN is the higher-margin pure-play with the cleanest balance sheet.

🌏 KEY DRIVERS TO WATCH

• China: 2nd-biggest market and the historical source of guidance pain (consumer-driven softness). Stabilization here = a major upside swing factor.
• 🇮🇳 India angle: Align is opening a manufacturing facility in Hyderabad — a tell on where management sees structural growth + a cost/supply-chain positive.
• ASP: Guiding ~1–2% price decline in 2026 on mix — volume has to carry the growth.
• Teen/kids penetration & zero-refinement cases driving utilization and margin.

 ANALYST VIEW

• Consensus: BUY / Overweight.
• Average 12-mo target ~$200–209 (Stifel Buy $210), range ~$175 low to ~$240 high.
• Implied upside ~15–25% from current levels to the average target.

 BULL CASE
• 80% de-rate is done; valuation reset to ~15x with growth returning.
• Net cash + aggressive buyback + 70% gross margins = quality at a discount.
• Structural growth market (aligners eating braces) with ALGN still #1.
• Technical downtrend-line break = the tape is confirming the fundamental turn.
• China stabilization + India expansion = optionality not priced in.

 BEAR CASE
• Share erosion is real — Envista, Dentsply, Angel Aligner all encroaching.
• Clear aligners are discretionary; consumer/macro softness hits volumes & ASPs.
• ASP guided DOWN — growth is volume-dependent.
• China remains a wildcard; legal/antitrust overhang ($58.5M settlement, ongoing legal costs).
• Still below the MA cluster — until $183 is reclaimed monthly, it's a downtrend bounce, not a confirmed reversal.

 GAME PLAN

• Support: $160 → $150 (breakout retest zone) → $120 (base low / invalidation).
• Trigger: Monthly close > $183 (reclaims MA cluster) = structure flips bullish.
• Targets: $231 (next resistance) → $260–300 (2023–24 range) → analyst avg ~$200–209 on the way.
• Invalidation: Monthly close back below ~$150 / loss of the breakout puts the falling-knife scenario back on the table.

The setup: a category-leading, net-cash, 70%-margin franchise that's been left for dead, just returned to growth, and is breaking a multi-year downtrend. High reward IF the MA cluster gives way — disciplined stops below $150.

It is  Pure our  Non-Biased Research and Not financial advice. Do your own research. 

NYSE: HRL | Consumer Staples / Packaged Foods | Mkt Cap ~$12.3B | Price ~$23.5

Hormel — owner of SPAM, Skippy, Planters, Jennie-O, Applegate & Black Label — has been cut nearly in half from its 2022 highs and just printed a 12-year low near $21. But the tape is starting to turn. Here's the full breakdown.

* TECHNICALS (Monthly Chart)

• Multi-year downtrend: HRL has bled ~55% from its ~$50 all-time high (2022) down to a ~$21 low — a brutal, grinding bear move back to a major decade-long support shelf.

• Demand zone holding: Price is sitting on the $20–21.50 support box — confluence with the 2018–19 breakout shelf AND the long-term rising moving average. This is THE line in the sand.

• Reversal kicking in: +11% in the last week, ~+9% over the last month off the low. First real sign of a momentum shift after years of selling.

• Capitulation volume: Notice the volume spike at the lows — it echoes the 2008–09 GFC bottom, which preceded a multi-year bull run. Big volume at decade support = potential accumulation, not just panic.

• Still below the MAs: Price remains under the declining ~$26 (fast) and ~$30–31 (slow) moving averages. The downtrend is NOT structurally broken yet — this is a bounce until proven otherwise.

• Levels that matter:
 → Support / invalidation: $21 (a monthly close below kills the setup)
 → Resistance 1: $26 (fast MA reclaim)
 → Resistance 2: $30–31 (the KEY multi-year pivot + slow MA confluence — the dashed line)
 → Long-term ceiling: $45–47 supply box
 → Reversal target if $30.50 flips to support: ~$35–36
 → Look at the volume Bars, which are showing too much volume last month with a strong upside candle. There is a very high probability that Institutional investors are trying to accumulate this stock in this downtrend and has much upside potential fromthese levels.

Bottom line on the chart: low-risk, high-reward setup — buyers are defending decade support with a tight invalidation, but bulls need to reclaim $26 then convert $30.50 to confirm the trend change.

🏢 THE BUSINESS

• 3 segments: Retail (~62%), Foodservice (~32%), International. ~40 brands hold #1 or #2 share in their categories.
• Foodservice is the crown jewel: 11 consecutive quarters of organic growth, +6–7% last quarter — higher-margin, sticky, away-from-home protein demand.
• Leadership reset: long-time CEO Jim Snee retired in late 2025; former CEO Jeffrey Ettinger returned as interim CEO (steady hand), with President John Ghingo driving the turnaround.
• Portfolio surgery: sold its low-margin whole-bird turkey business (kept the value-added Jennie-O brand) and offloaded 51% of Justin's — simplifying toward higher-margin protein.

📈 Q2 FY2026 RESULTS (reported May 28)

• Adj. EPS $0.40 vs $0.35 est — beat by ~13% 
• Revenue $2.97B (+2.5% YoY) — fractional miss, effectively in-line
• 6th straight quarter of organic sales growth (all 3 segments positive)
• Adj. operating margin EXPANDED to 9.9% (from 9.1%) — the margin inflection bulls want to see
• Operating cash flow surged to ~$179M (from ~$56M YoY)
• FY26 guide reaffirmed: sales $12.2–12.5B, organic +1–4%, adj. EPS $1.43–1.51 (GAAP EPS trimmed to $1.28–1.37 on the $61M turkey divestiture loss)

💰 VALUATION & MULTIPLES

• Trailing P/E ~16x | Forward P/E ~15–16x
• EV/EBITDA ~11x | P/S ~1.0x
• FCF ~$628M → FCF yield ~5%
• Beta 0.33 — extremely low-volatility / defensive
• Analyst targets: avg ~$26–29, range $22 (Stephens) to $30; consensus Hold-to-Buy. Note recent cuts (BofA $23, Stephens $22) AND a Goldman Buy at $25 — the Street is split.

⚠️ Honesty check: HRL is NOT cheap on a relative-multiple basis. At ~15–16x forward, it trades at a PREMIUM to its beaten-down peers. The 'cheap' argument is about its OWN history (near decade-low price, washed-out sentiment) and the 5% yield — not a peer-discount bargain.

⚔️ PEER COMPARISON (Forward P/E)

• Hormel (HRL): ~15–16x — premium (Dividend King, lowest leverage, protein/branded mix, foodservice growth)
• Kraft Heinz (KHC): ~11x
• General Mills (GIS): ~11x — organic sales -3%, near 52-wk low
• J.M. Smucker (SJM): ~9.6x
• Conagra (CAG): ~9x — negative TTM EPS
• Campbell's (CPB): trading at levels not seen since 2009
• Tyson (TSN): protein peer, beef segment posted an operating loss

Takeaway: the WHOLE shelf is bombed out. HRL earns its premium with quality and a fortress dividend record but you pay up for it.

🌐 SECTOR BACKDROP

• 2025 was historically brutal: NOT a single food manufacturer over $500M market cap finished 2025 positive. Large-cap food EPS fell ~18%.
• 2026 = modest recovery: large-cap food EPS forecast +4%; food organic sales +1.5% (vs +0.3% in 2025).
• GLP-1 (weight-loss drug) overhang remains the structural fear — but analysts (BofA) expect minimal near-term impact on these center-store/protein names.
• The setup: max-pessimism sector + early signs of EPS stabilization = classic contrarian hunting ground.

👑 THE DIVIDEND (the anchor of the thesis)

• Dividend KING — 60 consecutive years of increases; 392nd straight quarterly payment; uninterrupted since going public in 1928.
• Yield ~5% — near the high end of its history.
• ⚠️ The catch: payout ratio is stretched (~80%+ on adjusted earnings, well over 100% on GAAP). The dividend is covered by cash flow short-term, but EPS MUST recover for the streak to stay healthy long-term. This is the single biggest risk to the 'safe income' story.

🎯 THE BULL CASE (Reversal Thesis)

1. Highest-quality, lowest-leverage name (D/E 0.35, current ratio 2.47) in a washed-out sector.
2. Margin inflection underway — T&M cost program targeting ~$250M annual savings, with margins already expanding.
3. Foodservice momentum (11 straight quarters) + portfolio simplification toward higher-margin protein.
4. 5% yield + 60-yr dividend record = strong income floor attracting buyers at these levels.
5. Price at decade support with capitulation volume — the textbook spot for mean reversion.

🚨 THE BEAR CASE (Risks)
• Premium valuation vs peers leaves little margin for error
• Stretched payout ratio threatens the dividend if EPS doesn't recover
• Input cost inflation (pork, nuts/coffee for Planters), avian flu, slow China recovery, Planters integration drag
• Downtrend not broken until $30–31 reclaims — could just be a bounce
• GLP-1 secular demand fear hangs over the entire category

📌 GAME PLAN
• Bullish above the $21 box (tight invalidation below)
• Confirmation on a reclaim of $26 → trend change confirmed above $30.50
• Reversal target ~$35–36; you get paid ~5% to wait
• Next catalyst: Q3 FY2026 earnings — margin trajectory & T&M savings are the numbers to watch

This is a 'fallen quality + decade support + fat yield' setup. The chart says buyers are defending the line. The fundamentals say the turnaround is early but real. The risk says don't ignore that payout ratio.

Not financial advice. Do your own due diligence. 

• Strong Uptrend Intact — QQQ has been in a powerful uptrend since early April, rallying from ~$695 to a high of ~$750+, reflecting dominant bullish momentum with barely any meaningful pullback along the way.
• Consolidation Range Breakout — Price consolidated between roughly $700–$722 for ~3 weeks in May, forming a tight base. It has now broken out and extended ~100% of that consolidation range (~$22 range projected upward), reaching the measured move target near $744–$750.
• Full Measured Move Achieved — The chart clearly marks a 7.28% / ~$50.64 move off the consolidation low (~$695), with price hitting the 100% extension of the prior range — a classic signal that the immediate impulse leg is exhausted and short-term profit-taking is likely.
• Pullback Risk to ~$721–$715 Zone — The 50% retracement of the breakout range sits at ~$721.94, with the prior consolidation top near $715.07 acting as key support. A healthy, trend-confirming pullback would target this zone before any continuation higher.
• Bias Remains Bullish — The arrow on the chart suggests a minor dip, but the macro structure is strongly bullish. Any pullback toward $715–$722 should be treated as a buying opportunity rather than a reversal signal, as long as price holds above the $700 base.

• QQQ remains in a strong bullish structure, respecting the rising trendline support since the recent breakout from the 700 zone. Buyers continue defending higher lows.
• Price is currently consolidating inside a tight range between the 725–730 area after a sharp upside move, showing a healthy pause rather than weakness.
• Volume has declined during consolidation, which usually indicates sellers are not aggressive and momentum is being absorbed before the next move.
• As long as price holds above the ascending trendline and the 725 support zone, bullish momentum remains intact with potential continuation towards 735–738 levels.
• It may try to fill the downside gap and then try to bounce back from $721 support line.
• A clean breakout above the current consolidation range could trigger fresh upside expansion, while a breakdown below trendline support may lead to short-term pullback towards 721–722 support.

Company Details:

• Global fintech infrastructure giant — processes $10T+ in daily securities trades and 7B+ investor communications/year
• Two segments: Investor Communication Solutions (ICS) and Global Technology & Operations (GTO)
• Spun off from ADP in 2007; 15,000+ employees across 21 countries
• Near-monopoly in proxy distribution and shareholder communications, with ~98% client retention

Recent Financials (Q3 FY2026):

• Revenue: $1.95B (+8% YoY) — beat estimates by 2.6%
• Adjusted EPS: $2.72 (+11% YoY) — beat estimates by ~4%
• Recurring Revenue: $1.29B (+7%, +6% constant currency)
• 9-month net income: $726M (+56% YoY, partly boosted by one-time digital asset gain)
• Adjusted operating margin: 21.5% (compressed from 22.4% — key concern)
• FY2026 guidance raised: recurring revenue growth "at or above 7%", adj. EPS growth 10–12%
• Closed sales guidance lowered to $240–290M (from $290–330M) due to longer enterprise sales cycles
• Sales pipeline: $1B+ (up 20% YoY); deal origination up 25%

Valuation:

• Current price: ~$147–$150 | Market cap: ~$17.3B
• Forward P/E: ~15–16x vs. 5-year average of ~30x — near decade-low
• EV/EBITDA: ~19x vs. historical ~27x
• Dividend yield: ~2.60% vs. historical average ~1.5% — historically elevated
• DCF consensus fair value: ~$246/share → ~40% discount to intrinsic value
• PEG ratio: ~0.8–1.0x — growth not priced in

Technical Analysis (Weekly Chart):

• 45% decline from all-time high of ~$271.91 (mid-2025) — structural downtrend confirmed
• Both 50-week MA (~$195) and 200-week MA (~$196) now above price and acting as resistance
• Critical multi-year support zone at $120–$130 (held in 2018, 2020 COVID crash, 2022 bear market)
• Current price (~$147) is only 12–15% above that major support floor
• Key resistance levels: $165 → $170.89 → $183.75 → $195–196 (MA cluster)
• Chart projection suggests potential dip to support zone before V-shaped recovery
• Downtrend intact until weekly close above $196

Dividends & Capital Returns:

• Quarterly dividend: $0.975/share | Annual: $3.90 | Yield: ~2.60%
• 18 consecutive years of dividend increases — near Dividend Aristocrat status
• 5-year dividend growth CAGR: ~10.6%
• Conservative payout ratio: ~39–41% of earnings
• YTD shareholder returns (buybacks + dividends): $681M
• FCF target FY2026: >$1.1B

Analyst Consensus:

• Rating: Buy/Outperform (majority of coverage)
• Average 12-month price target: $243.60 (~60% upside from ~$150)
• Target range: $165 (UBS, Neutral) to $257 (Raymond James, Outperform)
• FY2026 EPS estimate: ~$9.78 | FY2027: ~$10.80
• Next earnings: August 4, 2026 (Q4 FY2026 full-year results)

Bull Case:

• Trading at decade-low valuation for a quality compounder
• ~$1B pipeline + 25% deal origination growth = delayed, not lost revenue
• AI, tokenization (Canton Network), and digital assets add long-term optionality
• Multiple re-rating to just 22–24x (below historical norm) → $215–$235 stock
• FCF yield approaching ~7.5% at current prices

Bear Case:

• Operating margin compression may persist as tech investment spending continues
• $3.46B in debt + new $500M notes at 5.75% interest = rising interest expense
• GTO segment growing only 3% — structural license revenue headwinds
• Tokenization could disrupt Broadridge's own traditional clearing business
• Insider selling created a negative sentiment overhang
• Technical downtrend firmly intact — could test $120–$130 support zone

Bottom Line:

• High-quality, recession-resilient fintech infrastructure at a historically rare discount
• Risk/reward appears asymmetric for 2–3 year investors at current prices
• Key risk: further margin deterioration or failure to convert the pipeline
• Key catalyst: Q4 FY2026 results + FY2027 guidance on August 4, 2026

• QQQ trend structure still looks bullish, and pre-market strength suggests continuation toward fresh highs.
• As long as momentum holds, QQQ could push another 3–4% higher from last close, targeting the 740–750 zone.
• Expecting a possible early-hour pullback before buyers step back in for another upside reversal.
• 715 remains the key support level to watch on a closing basis.
• A close below 715 could shift momentum sideways and keep QQQ trading in the 700–715 range for the rest of the week.

• QQQ continues to trade inside a well-defined consolidation range between $700 support and $715 resistance, with price currently testing the upper boundary of the range.
• The $715–$718 zone is acting as a major short-term resistance area, where sellers have repeatedly stepped in and rejected higher prices.
• Bulls are still maintaining short-term momentum as long as QQQ holds above the mid-range support near $710–$712, keeping the structure bullish inside the range.
• A strong breakout and sustained close above $718 resistance could trigger further upside continuation and open the path toward fresh highs and momentum expansion.
• However, the current setup also suggests a high probability of rejection near resistance, especially after multiple failed breakout attempts in the same zone.
• If QQQ fails to break above resistance, price may rotate lower toward the $700 support area, which remains the key demand zone to watch for the next directional move.

The Stock Nobody's Talking About — But Maybe Should Be

RingCentral is down 90% from its 2021 peak of $480. Most investors wrote it off years ago. But quietly, behind the scenes, something has changed. The company just posted its first-ever GAAP profitable quarter, free cash flow is heading toward $600M this year, and AI products are doubling year over year. This isn't a broken business — it's a forgotten one. And forgotten stocks with improving fundamentals are where the best returns hide.

💰 Fundamentals

• Revenue: $2.52B TTM | Q1 2026: $644M (+5.3% YoY)
• Annual Recurring Revenue: $2.71B — 97% subscription-based, highly predictable
• Q1 2026 GAAP EPS: +$0.35 (vs –$0.11 same quarter last year — flipped profitable)
• Non-GAAP EPS FY26 guide: $4.85–$5.01 — raised guidance, +13% YoY
• GAAP operating margin Q1: 7.8% — record high (was 1.7% a year ago, +610 bps)
• Free cash flow Q1: $141M | FY26 guided: $590–$605M
• Gross margin: 80%+ on subscriptions
• Net revenue retention: 99%+ — nearly zero customer churn
• Market cap: ~$3.8B | Price-to-FCF: just 6.3× — one of cheapest in SaaS
• Total debt: $1.8B convertible notes — being paid down with FCF

🤖 The AI Angle

• AI products now 10%+ of total ARR — doubled year over year
• 11,800 businesses using AI Receptionist across healthcare, legal and finance
• New integrations with Shopify, Calendly and WhatsApp — ecosystem expanding
• FCF per share FY26 guided at $6.90 — top decile across all SaaS companies

📈 Technical Setup

• Stock down ~90% from 2021 ATH of $480 — but up 71% over the past year
• 52-week range: $22 – $52 | Currently ~$43
• Multi-year base formed between $22–$45 on the weekly chart (highlighted on chart)
• Price breaking out above the consolidation zone — early recovery signal
• All longer-term EMAs still above price — full recovery takes time
• Analyst price targets: $32 (bear) → $45 (avg) → $55 (Raymond James) → $130 (DCF fair value)

✅ Bull Case

• Trading at 6.3× FY26 free cash flow — absurdly cheap for a 99% retention SaaS business
• GAAP profitability achieved for the first time — this is a structural shift, not a one-quarter fluke
• Operating margin expanded from 1.7% to 7.8% in just four quarters — discipline is real
• AI revenue doubling YoY — 10% of ARR and growing fast, monetization is working
• FY26 FCF of ~$600M on a $3.8B market cap = 15%+ FCF yield — rare in tech
• Share buybacks reducing count 5–6% annually — EPS growing faster than revenue
• Net retention above 99% — customers aren't leaving even as growth slows

⚠️ Bear Case

• Revenue growth of 4–5% is too slow for a tech multiple — market may keep valuing it cheap
• $1.8B in convertible debt weighs on balance sheet and limits flexibility
• Microsoft Teams bundles UCaaS for free — structural competitive pressure that won't go away
• Stock-based compensation of $240–245M annually overstates true free cash flow quality
• Analyst average target of ~$45 barely above current price — Wall Street has low conviction
• Stock still –90% from ATH — sentiment scarred, re-rating requires a sustained catalyst
• Negative GAAP ROE due to historical losses — looks ugly on standard screeners

🎯 Bottom Line RingCentral is one of the most interesting setups in tech right now — and almost nobody is paying attention. You have a $2.5B ARR cloud business with 99%+ customer retention, 80% gross margins, and $600M of annual free cash flow trading at just 6.3× that cash flow. The narrative has shifted: the company is profitable, margins are expanding at a record pace, and AI is becoming a real revenue contributor.

The risk is real too. Revenue growth is slow, Microsoft is a permanent threat, and the debt load is not trivial. This is not a momentum stock — it's a patient investor's stock.

The single most important catalyst to watch: AI ARR crossing 15–20% of total revenue. If that happens, the multiple re-rates meaningfully and the stock has a clear path toward $60–$80.

Watch: Q2 2026 earnings — revenue growth rate and AI ARR update are the two numbers that matter most.

🔺  QQQ Chart Analysis on(1 Hr) Time Frame — May 20, 2026

1. Trendline Intact Since April Lows
QQQ has been riding a clean ascending trendline from the April lows (~$565) all the way to the recent highs near $720 — a near 27% rally in under 2 months. Price is currently testing this trendline as support after pulling back from all-time highs.

2. Distribution Zone / Topping Pattern
The pink shaded zone between ~$700–$715 marks a clear supply/distribution area. Price spiked to ~$720, got rejected, and is now consolidating inside this box. This is a classic "re-test after breakout" scenario — bulls need to hold above $700 to maintain momentum.

3. Current Price Sitting at a Critical Level
QQQ closed at $701.53 — right at the lower edge of the highlighted zone and just above the $700 psychological round number. A close below $700 would be a warning sign. Above $706–$710 and bulls are back in control.

4. NVDA Earnings Tonight = Major Catalyst
NVIDIA reports Q1 FY2027 earnings after the bell TODAY. Street expects ~$1.75–$1.78 EPS and ~$78.5B in revenue (+79% YoY). NVDA is the single largest weight in QQQ and has been responsible for a significant chunk of QQQ's recent rally. A beat + strong guidance could send QQQ back above $710. A miss or weak guidance? Expect a test of $690–$695.

 5. NVDA Has a "High Bar" Problem
Despite a 97% expected beat probability, NVDA has actually fallen in 3 of its last 4 earnings reports even after beating estimates. The stock is up 20% in the past month alone — meaning a lot of good news is already priced in. Watch Jensen Huang's comments on Rubin chip ramp, China sales, and AI capex for the real market-moving signals.

6. Key Levels to Watch
• Support: $700 (psychological) → $693 (trendline retest)
• Resistance: $706–$710 (distribution zone midpoint) → $715–$720 (recent highs)
• Scenario A (Bullish): NVDA beats + guides up → QQQ reclaims $710 and pushes toward $720+
• Scenario B (Bearish): NVDA in-line or misses → QQQ breaks $700, trendline test at ~$693
 

• QQQ is currently consolidating in a tight range between $700 support and $715 resistance after a strong rally from the April lows.
• A daily close above $715 would confirm a bullish breakout and could lead to further upside toward new highs.
• A daily close below $700 would signal a breakdown and may trigger a pullback toward the next major support near $670.
• The overall trend remains bullish as long as QQQ continues to hold above the rising trendline and the $700 support zone.
• Premarket trading is relatively flat, indicating that the market is waiting for a catalyst to break out of the current range.
• Focus on the closing price rather than intraday volatility to confirm whether the breakout or breakdown scenario is playing out.

WHR is a high-risk, high-reward turnaround play. The business valuation is now extreme: trading at 0.16× revenue on a $15B business with iconic brands (KitchenAid, Maytag, Whirlpool) but genuinely under stress — dividend cut, negative FCF, EPS guidance slashed repeatedly.

💰 Fundamentals

• Revenue: $15.2B (TTM) — one of the largest appliance makers in the world
• Q1 2026 EPS: –$0.56 (vs +$1.70 same quarter last year)
• FY26 EPS guidance: $3.00–$3.50 (non-GAAP) — cut multiple times this year
• EBIT margin Q1: just 1.3% (was 5.9% a year ago)
• Free cash flow Q1: –$896M — deeply negative
• Market cap: only ~$2.7B on $15B+ revenue = trades at 0.16× sales
• Morningstar fair value estimate: $91 (117% upside from current price)
• DCF intrinsic value estimate: $158

📈 Technical Setup

• Stock has fallen ~78% from its 2021 all-time high of $195
• Down 62% from its 52-week high of $112
• Trading near 14-year lows — extreme fear priced in
• RSI near 31 — approaching oversold
• All EMAs (20, 50, 200) are above current price — deep downtrend
• Analyst price targets range wildly: $32 (RBC, Sell) → $145 (bull case)
• Average analyst target: ~$67–74 = 60–75% upside from here

✅ Bull Case (Why it could recover)

• Trades at 0.16× revenue — historically extreme cheapness for this company
• Domestic manufacturer = only 5% tariff impact vs 10–15% for import-heavy rivals — major competitive edge
• Largest price increases in a decade being pushed through — 3 years of unrecovered inflation finally being passed to consumers
• $115M+ in cost cuts targeted this year; $150M structural savings longer-term
• KitchenAid small appliances growing double-digits — brand is intact
• $1.1B equity raise completed → $900M+ debt being paid down = balance sheet stabilizing
• Housing market recovery = huge pent-up appliance replacement demand

⚠️ Bear Case (Real risks)

• Dividend suspended — major red flag
• EPS guidance has been cut repeatedly (from ~$10 early 2025 → $3.00–3.50 now)
• Goldman Sachs downgraded to Neutral; RBC has a Sell rating with $32 target
• Equity raise diluted shareholders (share count went from 57M → 71M+)
• S&P credit downgrade — balance sheet under stress
• North America demand "weakest since 2008" — may not recover quickly

Bottom Line WHR is a classic deep value contrarian bet. The business generates $15B in revenue with iconic brands (Whirlpool, KitchenAid, Maytag) — but it's in the middle of a painful restructuring. If you believe in housing recovery and management's ability to cut costs and raise prices, the upside is massive (2×–3× from here). If demand stays weak, the bleeding continues. This is high risk, high reward — not for the faint-hearted.

• QQQ appears to be forming a double top near $718, a critical resistance zone that aligns with key Fibonacci extension levels.
• The recent U.S.–China summit outcome has triggered profit-taking, increasing the probability of a short-term market reversal.
• An inverted hammer on the 4-hour chart at record highs suggests buyers are losing momentum and sellers are beginning to take control.
• A decisive break below $710 would confirm an intraday trend reversal and likely accelerate downside pressure.
• If QQQ closes below $700, it would mark a significant technical breakdown and open the door for a deeper correction toward the $675 support zone.

The Business Specialty natural & organic grocery chain. 483 stores across 25 states. Growing fast — opened 40+ new stores planned for 2026.

Fundamentals (Strengths)

• Revenue: $8.9B (up 14% in 2025)
• Gross Margin: 38.8% — excellent for grocery
• EPS: $5.24 TTM | Forward guide: $5.32–5.48
• ROE: 38.2% — world-class capital efficiency
• Free Cash Flow: $362M
• Clean balance sheet: $252M cash, zero debt drawn on credit line
• Buying back shares aggressively ($1B buyback program)
• 5-year EPS growth rate: 16.8% annually
   

Technical Setup

• Stock dropped ~50% from its 2025 highs (~$175) — now in recovery
• Currently reclaiming the 20 & 200-week EMA ($85.62) — key level
• Strong base built between $65–$85
• Upside targets: $95 → $105 → $134
• 11.3% short interest = potential short squeeze fuel
• Low beta (0.68) = less volatile than the market
   

Bull Case (Why it can go up)

• 40+ new stores in 2026 = consistent growth engine
• 53rd fiscal week adds ~$200M in extra sales + $0.21 EPS
• Analyst average price target ~$99 (15%+ upside from here)
• Health/organic food trend is structural, not a fad
• Aggressive buybacks shrink share count = EPS grows faster
• At 14.4× forward earnings — reasonably priced

Bear Case (Risks to watch)

• Comparable store sales went negative: –1.7% in Q1 2026
• EPS declined year-over-year (Q1: $1.71 vs $1.81 last year)
• 2026 guidance came in below analyst expectations
• Big competitors (Whole Foods, Trader Joe's) fighting for same customer
• Still –50% from 52-week high — sentiment hasn't fully recovered
• Shareholder lawsuit filed Jan 2026 — headline risk

Bottom Line SFM is a high-quality business going through a temporary rough patch. Margins are strong, cash flow is solid, and the store expansion keeps growing the top line. The stock is technically recovering from a big selloff and sitting at a key level. If Q2 comp sales stabilize, this could be the setup for a meaningful move toward $100–$105. Key risk: if traffic doesn't recover, the stock stays range-bound.

After a Vertical Rally, QQQ Could Be Ready for a Sharp Reversal. The Best Short Setup in Weeks May Be Developing Right Now.

• QQQ opened with a gap down and is currently struggling to reclaim the prior day’s low near $712, which is acting as an immediate resistance zone. This suggests that buying momentum may be fading at current levels.
• After an exceptionally strong one-way rally from the April lows, the probability of a short-term trend shift is increasing as price approaches overextended territory.
• If QQQ fails to close back above $712 and cannot sustain strength above this level, it would strengthen the case for a near-term market reversal and confirm that sellers are starting to regain control.
• Given the magnitude and speed of the recent advance, even a modest pullback could trigger a sharper correction as traders begin locking in profits. A retracement of 10% to 15% would not be unusual under these conditions.
• From a risk-reward perspective, this area offers an attractive setup for a tactical short position, with a defined stop loss above $718 and substantial downside potential if the current rally loses momentum.

• Despite a nearly 10% drawdown, the S&P 500 recovered to near all-time highs within just six weeks, showing strong market resilience.
• The latest rebound was one of the fastest on record, with the index recovering pre-conflict levels in only 11 trading sessions.
• Markets continue to price in optimism even as the Iran conflict remains unresolved and geopolitical uncertainty persists.
• The Nasdaq 100 posted a historic 13-day winning streak, while the S&P 500 and Russell 2000 gained 9% and 11%, respectively during the rally.
• Faster recoveries are being driven by strong liquidity, evolved market structures, and expectations of supportive monetary policy.
• Investors increasingly prefer staying invested during geopolitical volatility, as history continues to reward long-term market participation.

• QQQ has delivered a strong breakout above the major resistance zone near $636, which had previously capped price action for several months. This breakout confirms fresh bullish momentum in the broader Nasdaq market.
• The breakout was followed by aggressive continuation buying, showing strong participation from institutional flows and momentum traders. Price is now trading well above key moving averages, keeping the short-term and medium-term trend firmly bullish.
• Momentum indicators continue to support the upside structure, with RSI sustaining in strong bullish territory — a sign that buyers still control the trend despite the sharp rally.
• The recent rally also confirms a higher-low and higher-high market structure on the daily timeframe, indicating that dip-buying demand remains strong and trend continuation is still active.
• As long as QQQ sustains above the breakout zone around $636-$640, the market may continue extending toward the next major upside target near $718, which aligns with the projected continuation range from the breakout structure.

Six Flags owns 41 theme parks. Millions of people walk through their gates every summer. And yet, the stock has lost 70% of its value. Something is very broken — but is it the business, or just the market's patience?

The story

• Cedar Fair + legacy Six Flags merged July 2024 → now ticker FUN
• North America's largest theme park operator — 41 parks, 15 water parks, 9 resorts
• 2025 was a disaster: CEO fired, attendance missed, revenue disappointed

Why it's crushed

• FY2025 net loss of $1.60B; Adj. EBITDA only $792M — far below targets
• Only $107M cash vs $5.52B debt — current ratio 0.52x, highly distressed balance sheet
• Short interest at 19.4% of float — market has very low conviction

Why it might be cheap

• P/S ratio of just 0.6x, down from 1.3x a year ago — fraction of the S&P 500's 3.4x 
• DCF fair value estimated at $54.71 — stock trading more than 60% below $54 levels 
• New CEO since Dec 2025; $200M synergy target mostly unrealized

Technical picture (from chart)

• Down ~70% from $70 ATH; price below all three EMAs (20/50/200)
• Monthly RSI ~32–35 — approaching oversold; massive volume spike = capitulation signal
• Analyst consensus: Buy, avg target $27.69 — ~48% upside from current levels
• Yellow support box ($14–16) held for 30+ years — the last line of defence

• The semiconductor sector is witnessing a massive rally as global AI demand continues to accelerate across industries.
• The Philadelphia Semiconductor Index has surged 54% since late March, recording its strongest 25-day performance since the dot-com era in 2000.
• AI-driven growth in data centers, cloud computing, and advanced chip production is fueling strong momentum in semiconductor stocks worldwide.
• Samsung Electronics reached a historic $1 trillion market capitalization, highlighting growing investor confidence in AI-related technology leaders.
• South Korea’s Kospi Index climbed above the 3,000 level, gaining more than 70% year-to-date, supported largely by semiconductor and AI optimism.

• Trend Context: The market is currently in a strong bullish momentum phase, with higher highs and higher lows visible on the daily chart.
• Key Support Level (668): The level around 668 acts as a critical support. As long as price holds above this, the bullish structure remains intact.
• Breakdown Scenario: A daily close below 668 would signal potential weakness and could trigger a shift toward downside momentum.
• Immediate Resistance (675): For today’s session, 675 is the key level to watch on the upside.
• Upside Confirmation: If price sustains above 675, it increases the probability of a ~1% intraday upside move, indicating continuation of the current bullish momentum.

• Oil Price, bond yield, war news  but still market is holing on higher levels
• Technically  SPX is strong uptrend on all time frames
• Yesterday we close little lower after Friday shooting star candle 
• Friday Closing is still important here, only go long once we close above Friday's close
• Short term support is around 7140 and main support is at 7000

Trend: Bullish, but at a decision zone near ATH. The trend will turn bearish below $668

Key Levels:

• Resistance: 676
• Support: 668

Bullish Scenario:
Sustained breakout above 676 → continuation toward 690+

Bearish Scenario:
Break & hold below 668 (loss of 1H EMA support) →

• 652 (first target)
• 636 (extended move)

Context:
Momentum is strong but slightly stretched (RSI elevated).
This is not a trend reversal yet — only a potential pullback setup.

Plan:
Wait for confirmation (no anticipation). Trade acceptance, not levels.

“56 years of unbroken dividends didn't happen by accident — and they didn't stop here either.” - Abbott Lab.

Business

• 4 segments: Medical Devices, Diagnostics, Nutrition, Established Pharma (EPD)
• Key products: FreeStyle Libre CGM, Alinity, Cologuard (via Exact Sciences), heart devices, Ensure
• Operates in 160+ countries; ~55% international revenue

Q1 2026 results

• Revenue $11.16B, +7.8% YoY; adj. EPS $1.15, +6% — beat by $0.01
• Medical Devices +8.5%; Cancer Diagnostics +13%; EPD +9%
• Rapid/Molecular Diagnostics –10% — weak respiratory season
• CGM quarterly sales hit $2B; expected to re-accelerate to double digits in Q2

Guidance (FY2026)

• Full-year sales growth 6.5–7.5%; FY EPS midpoint $5.48 — cut $0.20 due to Exact Sciences dilution
• Exact Sciences acquisition ($21B, closed March 23) adds ~$3B incremental sales

Valuation

• Forward P/E 17.87x — 7.9% below medtech industry median of 19.4x
• GF Value $126.39 — stock trading ~20% below fair value; rated "Modestly Undervalued"
• Analyst avg target ~$120–140; consensus Strong Buy (32 analysts)

Balance sheet

• Cash $8.94B; LT debt jumped from $9.9B → $29.6B post-acquisition
• Debt/Equity 0.27x; current ratio 1.58x; net cash position –$5.2B
• Dividend $2.44/share, yield 2.48% — 56-year unbroken streak

Technicals (from chart)

• Down ~37% from $142 ATH; trading near 52-week low ~$87–89
• Monthly StochRSI ~35–51 — low range but not deeply oversold like BSX
• Key support $79.32; resistance $112–$114
• Distribution volume visible 2024–2026; downtrend not yet broken

The stock dropped 46% — but the business is still growing and much potential to start new uptrend. Here's what you need to know in details.

Business

• Medical devices: stents, cardiac rhythm, EP, endoscopy, neuromodulation
• Two segments: Cardiovascular & MedSurg
• Sells globally; ~36% international revenue

Q1 2026 results

• Revenue $5.20B, +11.6% reported / +9.4% organic
• Adj. EPS $0.80, +6.7% YoY — beat estimates
• Cardiovascular +13.5%, MedSurg +7.8%
• Free cash flow $170M in Q1; $3.66B TTM

Guidance (FY2026)

• Revenue growth cut to 7–8.5% (was higher)
• Adj. EPS $3.34–3.41, +9–11%
• Headwinds: Watchman softness, EP share loss, urology turnover

Valuation

• Forward P/E 18.3x — below sector median 19.8x
• EV/EBITDA 19.4x
• GF Value $103.93 → ~80% above current price
• Alpha Spread DCF $73.26 → ~28% upside
• Analyst avg target ~$96, consensus Strong Buy (21 analysts)

Balance sheet

• Cash $1.97B, Debt $11.97B, Net debt $10.0B
• Debt/Equity 0.49x — manageable
• Gross margin 68.8%, net margin 17.3%
• No dividends

Technicals

• Down 46% from $109.50 peak
• StochRSI ~25–29 — deep oversold
• Key support $45.62, resistance $74.60 / $84.90
• High-volume selloff = institutional distribution signal
• Trend: weekly downtrend, parabolic reversal pattern

Bull case

• Cheap on forward metrics vs peers
• Strong organic growth & FCF
• Deep IP moat in cardiac rhythm
• Oversold — historically bounces from here

Bear case

• Guidance slashed; 3 specific segment headwinds
• $10B net debt, no dividend cushion
• Technical damage severe; more downside possible towards $45
• Class action lawsuit + Axios stent recall overhang

MAJOR EARNINGS TODAY 

Attractively valued, but a "show-me" story

At ~11.7x FCF and ~2.9x EV/Revenue, WDAY trades near its cheapest level in years despite $2.8B in annual free cash flow and a $28B+ backlog. The core thesis rests on: (1) FCF compounding at 15–20%/yr as margins expand toward 32–35%, (2) Flex Credits monetization proving that AI upsell offsets any seat-count pressure, and (3) Finance management penetration widening the TAM. The key risk is that growth structurally slows to high-single digits if agentic AI reduces headcount and therefore per-seat licensing. Analysts' consensus Buy with avg. target ~$182 implies ~47% upside. Entry at current levels appears compelling on a 3–5 year view, provided the AI model transition executes.

Fundamentals — What the numbers say

• In fiscal year 2026, Workday posted total revenues of $9.55 billion, up 13.1% from fiscal 2025, with subscription revenues of $8.83 billion growing 14.5% year-over-year. Free cash flows reached $2.78 billion, a 26.7% increase from the prior year, and non-GAAP operating income came in at $2.82 billion, or 29.6% of revenues. These are genuinely strong cash generation numbers for a company now trading near its cheapest EV/FCF in years.
• Workday ended fiscal 2026 with a 97% gross revenue retention rate, a $28.1 billion subscription backlog, over $400 million in emerging AI ARR, and AI-linked expansion deals that averaged nearly 50% larger in size. That backlog figure is essentially multi-year revenue already under contract — a meaningful cushion against near-term uncertainty.

The core Risk: AI & the per-seat model

• The takeaway from Workday's fiscal Q4 2026 report is clear: the era of "easy growth" in SaaS is over. The 12–13% growth guidance is a sober admission that the transition to an agentic workforce is a marathon, not a sprint.
• Workday is pivoting its pricing architecture with the introduction of Workday Flex Credits — a consumption-based model that allows enterprises to pay for specific AI outcomes and "agents" they utilize, reflecting the industry-wide move away from headcount-based pricing. This is the right strategic direction, but execution risk is real.

AI Strategy & Growth Levers

• Workday positions itself as an enterprise AI platform managing people, money, and agents, serving more than 11,500 organizations and over 75 million contracted users. The company is expanding into AI agents for hiring, frontline worker experiences, and financial processes, with targeted acquisitions of Flowise, Paradox, Sana, and Pipedream to deepen AI capabilities.
• Workday's penetration in the Finance market is roughly half of its HCM market share — success there could effectively double the company's total addressable market. International growth is another greenfield, as the company still generates the vast majority of its revenue in the U.S.

Valuation — Finally reasonable

• Simply Wall St estimates WDAY is trading at roughly 51.9% below their estimate of its fair value. At ~$124/share, the market prices in considerable pessimism: ~11.7x FCF, ~2.9x EV/Revenue, and ~13.5x non-GAAP earnings — well below historical SaaS premiums.
• Based on 32 Wall Street analysts, the average 12-month price target is $182.59 with a high of $300 and a low of $115, representing about 47% potential upside from current levels. The consensus rating is Moderate Buy, with 19 buy ratings and 13 hold ratings.

Technical Breakdown & Trend Shift

• Workday (WDAY) is showing a clear trend breakdown after years of higher highs and higher lows. Price has decisively fallen below key moving averages (21, 50, 200 EMA), with bearish alignment now forming. This shift confirms a transition into a downtrend, supported by strong downside momentum and heavy selling pressure. RSI near oversold (~30) may trigger a short-term bounce, but it doesn’t signal a confirmed bottom in a weakening structure.
• From a levels perspective, $120 is the immediate support, with $100 as the next psychological zone. On the upside, $150–$180 becomes strong resistance, followed by the 200 EMA near ~$215. Unless price reclaims that zone, the broader outlook remains bearish, and any bounce is likely to be a relief rally within a larger downtrend.

Bottom line for a 3–5 year investor

• WDAY is a high-quality compounder undergoing a painful business model transition. The bear case is real — AI agents could structurally reduce headcount-based licensing revenue. But the bull case is also compelling: $2.8B in annual FCF, a $28B backlog, 97% retention, founder-led management, and a stock down ~60% from peak. If the Flex Credits/consumption model gains traction and Finance module penetration deepens, the stock has significant re-rating potential.

This is not financial advice. WDAY involves meaningful execution and AI-disruption risk. Consider your own risk tolerance and consult a financial advisor.

SPY is currently trading near its recent highs, and the trend is still strong on the upside. But if you look closely, we’ve seen a similar pattern before (Oct 2025) — and it’s worth paying attention.

Back in October:

• Market made a new high
• Everyone got bullish
• Then suddenly, a sharp reversal happened
• Price dropped quickly to the Fibonacci golden zone (around 0.618)
• After that, it even retested the previous swing low (~$630)

Now, the current structure is starting to look similar:

• Price is again near highs
• Momentum is slowing a bit
• RSI is also near higher levels (not much room left)

Key levels to watch now:

• $694 → This is very important
  • 21-day EMA
  • Previous breakout zone
    👉 This should act as the first strong support
• If this level breaks:
  • Next downside could be towards $680–$670 (Fib zone)
  • And in worst case, a deeper move towards $630 swing low

Simple takeaway for beginners:

• Don’t blindly chase the market at highs
• Markets often pull back after strong rallies
• Always watch support levels before entering trades

👉 Trend is still up, but risk is increasing near highs. Manage your positions smartly with a strict stop loss level of $617, which is the ATH level.

Major earnings Today 

The PHLX Semiconductor Index (^SOX) enters the week on a remarkable 18-session winning streak, gaining over 10% this week and nearly 50% year-to-date. Leading the surge, Intel has jumped almost 90% in April, while AMD has climbed around 65%, reflecting strong momentum across chipmakers.

However, early signs of fatigue are emerging as profit-taking begins to set in. Stocks like ARM Holdings, Broadcom, and Marvell have pulled back, with reports suggesting institutional investors are starting to sell into the rally.

Bottom line: The semiconductor trend remains bullish, but early distribution signals hint that a short-term consolidation or correction may be underway.

Key Highlight Headings

1. U.S.-Iran Talks Stalled  

Negotiations remain stuck, keeping geopolitical risk elevated.

2. Strait of Hormuz Disruption  

The near-shutdown is pushing oil prices higher and weakening risk sentiment.

3. Earnings Season Accelerates  

Around 35% of the S&P 500 is reporting this week.

4. Hyperscalers Under the Spotlight  

Alphabet, Microsoft, and Meta will test whether AI spending still supports the rally.

5. Fed Decision in Focus  

Rates may stay on hold, but the Fed’s tone on inflation and energy shocks will be critical.

6. Global Central Banks to Watch  

ECB, BOE, and BOJ updates could quickly shift rate expectations.

7. Key U.S. Data Ahead  

Q1 GDP and PCE inflation will help shape the next market narrative.

Busy week ahead: geopolitics, oil, earnings, central banks, and macro data are all set to move markets.

Nvidia is clearly the AI leader by scale and dominance, AMD is the fast-growing challenger, and Intel is the turnaround story benefiting from AI CPU demand—all riding a massive multi-year AI-driven cycle.

• NVIDIA
  • FY2026 revenue: $215.9 billion (+65% YoY) 
  • Market cap: $5 trillion (world’s most valuable company) 
  • Controls ~80% of AI accelerator market, dominating GPUs 
• AMD
  • FY2025 revenue: $34.6 billion (record, +34% growth) 
  • Market cap: ~$564B+ 
  • Strong growth driven by EPYC server CPUs & AI chips
• Intel
  • FY2025 revenue: $52.9 billion 
  • Recent quarter: $13.58B revenue, beating estimates 
  • Data center & AI segment: ~$5.1B revenue 
  • Market cap: ~$405B+ 
•  Sector Insight:
  • Semiconductor index up 40%+ YTD, with AI demand driving growth 
  • Industry earnings expected to grow ~109%, far above broader tech

Sector Insights

• The semiconductor sector is witnessing a strong rally, largely driven by the rapid expansion of artificial intelligence (AI).
• Demand for AI chips and data center infrastructure is surging, boosting revenue outlook across the industry.
• Intel is showing signs of a comeback, supported by rising demand for CPUs in AI workloads.
• NVIDIA continues to lead the AI GPU market, benefiting the most from AI-driven growth.
• AMD is gaining market share, especially in server and AI chip segments.
• The broader semiconductor market has reached record highs, reflecting strong investor confidence.
• Despite bullish momentum, valuations are elevated, making the sector prone to short-term volatility.

Lithium carbonate prices in China climbed to CNY 173,000 per tonne, marking a three-month high and nearly 50% year-to-date surge, driven by strong EV battery demand and rising crude oil prices accelerating the shift toward clean energy vehicles.

Additional momentum is coming from global EV expansion, battery storage demand, and policy support—reinforcing lithium’s role as a critical raw material in the energy transition.

Stocks in Focus - ALM, RIO, SQM, & LIT etf

The trend remains firmly bullish, with price showing strong upside continuation. After a healthy pullback, QQQ has resumed its upward momentum, indicating buyers are back in control.

With the current structure, there is potential for an additional ~3% upside from here. As long as momentum sustains, the path of least resistance remains higher.

Avoid counter-trend trades—this is a market where following the trend is key for short-term positioning.

Expectation: A move toward the $676 zone within the next 3–4 trading sessions if momentum persists.

• Market is struggling to cross 7150 levels
• We can see kind M top and RSI divergence and it confirmed with yesterday's close
•  We saw flash dip to 7050 yesterday which was bought immediately
• Technically SPX it now in overbought zone so need to Patrice caution 
• Short term support is around now at 6980 and main support is at 6800
• Looks like we are heading toward flat weekly close

• Market Closed at new high yesterday after 2 days of small pull back
• We can see kind M top and RSI divergence, so today close is very Important
• If market close in red today this can lead to a bit bigger drop below 7000
• Technically SPX it now in overbought zone now
• Short term support is around now at 6980 and main support is at 6800
• If SPX close at new high today, than we can also expect weekly closing above 7200 tomorrow